Clinica Baviera S.A (CBAV) | Stock Overview & Key Data
Clinica Baviera S.A. | Mid-cap | Healthcare
Clinica Baviera S.A. | Mid-cap | Healthcare
Clinica Baviera S.A Performance Comparison
Stock Range
Today's Range
Low: €42.40
High: €44.70
on September 23, 2025
52 Week Range
Low: €29.70
High: €46.50
on April 7, 2025
on August 29, 2025
All-Time High: €46.50 on August 25, 2025
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Market Cap
€694.6M
EPS
2.40
P/E Ratio (TTM)
17.92
Forward P/E
24.43
P/B Ratio
7.73
PEG Ratio
24.43
Div. Yield
7.97%
ROE
46.33%
Beta
0.845
Debt to Equity
70.72
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
19.71%
Profit Margin
13.51%
Returns and Earnings
Return on Assets (TTM)
16.56%
Return on Equity (TTM)
46.33%
EBITDA
€80.5M
Net Income (TTM)
€39.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€18.07
Quarterly Revenue Growth (YoY)
12.00%
Quarterly Earnings Growth (YoY)
-9.80%
Dividend Information
Last 12-Month Dividend
€3.14
Current Dividend Yield
7.97%
3-Year Average Dividend Yield
4.15%
3-Year Average Annual Dividend
€1.48
3-Year Total Dividends
€4.44
Ex-Dividend Date
June 11, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Clinica Baviera S.A CBAV | 694.58M Mid-cap | -4.67% | -5.51% | 10.28% | 22.22% | 36.19% | 20.85% | 126.98% | 404.71% |
| Pangaea Oncology PANG | 59.40M Small-cap | 1.16% | 1.16% | 2.35% | 0.58% | -1.69% | 18.37% | 23.40% | 16.78% |
| EuroEspes S.A EEP | 6.22M Small-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1.82% | 12.50% |
| Grifols, S.A GRF | 7.45B Large-cap | -0.83% | -3.95% | 17.57% | 29.60% | 25.90% | 17.34% | 34.12% | -52.40% |
| Laboratorios ROVI | 3.04B Large-cap | -1.84% | 1.82% | 8.89% | 11.79% | -8.13% | -18.56% | 33.03% | 89.68% |
| Almirall S.A ALM | 2.49B Large-cap | 3.76% | 3.57% | 9.23% | 14.51% | 38.42% | 31.07% | 17.65% | 20.08% |
Ownership & Short Interest
Insider Ownership
85.09%
Institutional Ownership
7.17%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
1K
Average 90-Day Volume
3K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CBAV's 52-week high and low?
- In the last 52 weeks, Clinica Baviera S.A reached a high of €46.50 (on August 29, 2025) and a low of €29.70 (on April 7, 2025).
- What is the market cap and P/E ratio for CBAV?
- Curious about Clinica Baviera S.A's size and valuation? Its market capitalization stands at 694.58M. When it comes to valuation, the P/E ratio (trailing twelve months) is 17.92, and the forward P/E (looking ahead) is 24.43.
- Does CBAV pay dividends? If so, what's the yield?
- Yes, Clinica Baviera S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 7.97%, and the company has paid an average of €1.48 per share annually over the past 3 years.
- Who are Clinica Baviera S.A's main competitors or similar companies to consider before investing?
When looking at Clinica Baviera S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Pangaea Oncology
PANG59.40M Healthcare Diagnostics & Research 18.37% 23.40% EuroEspes S.A
EEP6.22M Healthcare Diagnostics & Research 0.00% -1.82% Grifols, S.A
GRF7.45B Healthcare Drug Manufacturers - General 17.34% 34.12% Laboratorios
ROVI3.04B Healthcare Drug Manufacturers - Specialty & Generic -18.56% 33.03% Almirall S.A
ALM2.49B Healthcare Drug Manufacturers - Specialty & Generic 31.07% 17.65% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Clinica Baviera S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Clinica Baviera S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 46.33%, the Debt to Equity ratio from the most recent quarter is 70.72, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for CBAV?
- Looking at Clinica Baviera S.A's growth, its revenue over the trailing twelve months (TTM) was €289M. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.00%, and quarterly earnings saw a YoY growth of -9.80%.
- How much of CBAV stock is held by insiders and institutions?
- Wondering who owns Clinica Baviera S.A stock? Company insiders (like executives and directors) hold about 85.09% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 7.17%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.